References
- Guillot B., Bessis D., Dereure O. Mucocutaneous side effects of antineoplastic chemotherapy. Expert Opin Drug Saf 2004; 3: 579–87
- Bernstein T. Skin reactions to 5‐fluorouracil. N Engl J Med 1977; 297: 337–8
- Pramatarov K. D. Drug‐induced lupus erythematosus. Clin Dermatol 1998; 16: 367–77
- Yoshimasu T., Hiroi A., Uede K., Furukawa F. Discoid lupus erythematosus (DLE)‐like lesion induced by uracil‐tegafur (UFT). Eur J Dermatol 2001; 11: 54–7
- Moazzam N., Malik A. A., Mehdi S. A., Potti A. Treatment side effects. Case 3. Fluorouracil‐induced exacerbation of systemic lupus erythematosus. J Clin Oncol 2002; 20: 3032–4
- Dudley K., Micetich K., Massa M. C. Erythema with features of seborrheic dermatitis and lupus erythematosus associated with systemic 5‐fluorouracil. Cutis 1987; 39: 64–6
- Yoshimasu T., Nishide T., Seo N., Hiroi A., Ohtani T., Uede K., et al. Susceptibility of T cell receptor‐alpha chain knock‐out mice to ultraviolet B light and fluorouracil: a novel model for drug‐induced cutaneous lupus erythematosus. Clin Exp Immunol 2004; 136: 245–54